A Randomized Phase 3 Study of Tislelizumab in Combination With Sitravatinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Progressed on or After Platinum-Based Chemotherapy and Anti-PD-(L)1 Antibody

Project: Research

Project Details

StatusActive
Effective start/end date27/10/2126/10/26

Keywords

  • phase 3 study
  • treatment safety
  • treatment efficacy
  • lung cancer